Jennifer Lachey
Director Técnico/Científico/I+D en KEROS THERAPEUTICS, INC. .
Perfil
Jennifer Lachey's current job is Senior Vice President-Research at Keros Therapeutics, Inc. Her former jobs include being an Associate Director-Preclinical Pharmacology at Acceleron Pharma, Inc. from 2008 to 2012, a Senior Director at Seres Therapeutics, Inc. from 2015 to 2016, and a Senior Director-Preclinical Pharmacology at Ember Therapeutics, Inc. from 2012 to 2015.
Dr. Lachey obtained her undergraduate degree from Indiana University and her doctorate degree from the University of Cincinnati (Ohio).
Cargos activos de Jennifer Lachey
| Empresas | Cargo | Inicio |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2019 |
Antiguos cargos conocidos de Jennifer Lachey.
| Empresas | Cargo | Fin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/07/2016 |
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | 01/07/2012 |
Formación de Jennifer Lachey.
| Indiana University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KEROS THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| EMBER THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Lachey
